Literature DB >> 14960021

Growth hormone treatment in cartilage-hair hypoplasia: effects on growth and the immune system.

G Bocca1, C M Weemaes, I van der Burgt, B J Otten.   

Abstract

Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive disorder characterized by metaphyseal chondrodysplasia with severe growth retardation and impaired immunity. We studied the effects of growth hormone treatment on growth parameters and the immune system in four children with CHH. The effects of growth hormone on growth parameters are the most prominent in patients with the mildest growth retardation. However, the effects are temporary and last only for 1 year. There is no gain in final height. Serum immunoglobulins did not change during growth hormone treatment. We conclude that growth hormone treatment is not beneficial in children with CHH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960021     DOI: 10.1515/jpem.2004.17.1.47

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

1.  Growth patterns and the use of growth hormone in the mucopolysaccharidoses.

Authors:  L E Polgreen; B S Miller
Journal:  J Pediatr Rehabil Med       Date:  2010

2.  Evolutionary comparison provides evidence for pathogenicity of RMRP mutations.

Authors:  Luisa Bonafé; Emmanouil T Dermitzakis; Sheila Unger; Cheryl R Greenberg; Belinda A Campos-Xavier; Andreas Zankl; Catherine Ucla; Stylianos E Antonarakis; Andrea Superti-Furga; Alexandre Reymond
Journal:  PLoS Genet       Date:  2005-10       Impact factor: 5.917

3.  Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.

Authors:  Patrick Riley; Dennis S Weiner; Bonnie Leighley; David Jonah; D Holmes Morton; Kevin A Strauss; Michael B Bober; Martin S Dicintio
Journal:  J Child Orthop       Date:  2015-03-13       Impact factor: 1.548

Review 4.  Ribosomopathies: New Therapeutic Perspectives.

Authors:  Emilien Orgebin; François Lamoureux; Bertrand Isidor; Céline Charrier; Benjamin Ory; Frédéric Lézot; Marc Baud'huin
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.